Dariusz Pytel to Adenocarcinoma
This is a "connection" page, showing publications Dariusz Pytel has written about Adenocarcinoma.
Connection Strength
0.256
-
Use of Small-molecule Inhibitory Compound of PERK-dependent Signaling Pathway as a Promising Target-based Therapy for Colorectal Cancer. Curr Cancer Drug Targets. 2020; 20(3):223-238.
Score: 0.139
-
Inhibition of PERK-dependent pro-adaptive signaling pathway as a promising approach for cancer treatment. Pol Przegl Chir. 2017 Jun 30; 89(3):7-10.
Score: 0.117